Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 40 X posts from 26 X users, with an upper bound of 88,156 followers.

RT @DrMarkAwad: Great work from our fellow Biagio Ricciuti @BiagioMd @DanaFarber in #JITC on use of NGS to quantify TMB & immune checkpoint…

RT @DrMarkAwad: Great work from our fellow Biagio Ricciuti @BiagioMd @DanaFarber in #JITC on use of NGS to quantify TMB & immune checkpoint…

Effective use of NGS

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 36 additional X posts.